Thomas H. Glocer - Jun 30, 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Director
Signature
/s/ Jon Filderman as Attorney-in-Fact for Thomas H. Glocer
Stock symbol
MRK
Transactions as of
Jun 30, 2023
Transactions value $
$45,000
Form type
4
Date filed
7/5/2023, 04:36 PM
Previous filing
Jun 2, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 5.1K Jun 30, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Phantom Stock Award $45K +390 +0.43% $115.39 90.3K Jun 30, 2023 Common Stock 390 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.